When performing a group analysis, irisin was shown to have a positive correlation with the SBP percentile (R = 0.545, p = 0.024) and a negative association with MCP-1 (R = −0.514, p = 0.035) in patients with MetS. The gene discussed is CCL2; the disease is metabolic syndrome.